2023 DTRF Patient Meeting Presenters

Founded in 2007, the Patient Meeting is our signature patient support event and the centerpiece of the DTRF Together We Will Weekend. It includes educational lectures by leading clinicians, researchers, and other stakeholders. Content is geared toward topics of interest to our patient and caregiver community, but physicians are also encouraged to attend this foundational meeting. We are proud to announce this year’s presenters: 

Jeanne Whiting

Jeanne Whiting

President and Co-Founder, Desmoid Tumor Research Foundation

Welcome & Introduction

Candace Haddox, MD

Candace Haddox, MD

Medical oncologist, Dana-Farber Cancer Center

Desmoid Tumors 101/ Getting the most from your consultation and treatment plan

Bernd Kasper, MD, PhD

Bernd Kasper, MD, PhD

Professor, University of Heidelberg, Mannheim University Medical Center, Mannheim Cancer Center, Sarcoma Unit (Germany)

Latest edition of the global management consensus from ‘The Desmoid Tumor Working Group’

Alessandro Gronchi, MD

Alessandro Gronchi, MD

Chair, Sarcoma Service, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano (Italy)

Active Surveillance as a Desmoid Tumor Treatment/

Mock Tumor Board (Panelist)

Ryan Brunsing, MD

Ryan Brunsing, MD, PhD

Clinical Assistant Professor of Radiology, Director of MRI, Stanford University

MRI-guided cryoablation and HIFU in the treatment of desmoid tumors

Eldad Elnekave, MD

Eldad Elnekave, MD

Director, Kahn Unit for Interventional Oncology, Shaare Tzedek Medical Center (Jerusalem, Israel)

Arterial doxorubicin eluting embolization as a Desmoid Tumor Treatment/ 

Mock Tumor Board (Panelist)

Bernd Kasper, MD, PhD

Bernd Kasper, MD, PhD

Professor, University of Heidelberg, Mannheim University Medical Center, Mannheim Cancer Center, Sarcoma Unit (Germany)

DeFi: A phase 3 study of nirogacestat in adults with desmoid tumors.

Mrinal Gounder, MD

Mrinal Gounder, MD

Associate Professor, Sarcoma Medical Oncologist and Early Phase Drug Development (Phase I), Memorial Sloan Kettering Cancer Center, New York

RINGSIDE Phase 2/3 Trial of AL102 for Treatment of Desmoid Tumors (DT): Updated Phase 2 Results

Gabe Augdahl

Gabe Augdahl

Desmoid Tumor Patient

Palma Dileo, MD

Palma Dileo, MD

Sarcoma Medical Oncologist, University College London Hospitals

Mock Tumor Board (Co-Moderator)

Aaron Weiss, DO

Aaron Weiss, DO

Associate Professor, Department of Pediatrics, Division Chief, Pediatric Hematology-Oncology, Maine Medical Center

Mock Tumor Board (Co-Moderator)

Robert Lefkowitz, MD

Robert Lefkowitz, MD

Attending Radiologist, Memorial Sloan Kettering Cancer Center

Imaging of Desmoid Tumors

Kelly Mercier, PhD

Kelly Mercier, PhD

Principal Investigator, DTRF Patient Registry, Desmoid Tumor Research Foundation

An Update on the DTRF Patient Registry – September 2023

Marco Fiore, MD, FACS

Marco Fiore, MD, FACS

Sarcoma Service, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano (Italy)

What We’ve Learned from the International Pregnancy Study

Ravin Ratan, MD

Associate Professor, Sarcoma Medical Oncology, MD Anderson Cancer Center

Mock Tumor Board (Panelist)

Share this Post!